Evidence map›Paper›PMID 36517825›Full record

ArticleArchives of physiotherapy2022

Economic evaluation: a reader's guide to studies of cost-effectiveness.

J Haxby Abbott, Ross Wilson, Yana Pryymachenko, Saurab Sharma, Anupa Pathak, Jason Y Y Chua

Abstract read
In one paragraph

Article in Archives of physiotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer's disease: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Cost-utility of cochlear implantation in single-sided deafness and asymmetric hearing loss: results of a randomized controlled trial.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. An overview of the perspectives used in health economic evaluations.Cost effectiveness and resource allocation : C/E · 2024
    Review
  18. Cost-utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J Haxby AbbottCentre for Musculoskeletal Outcomes Research, Otago Medical School, University of Otago, Dunedin, New Zealand. haxby.abbott@otago.ac.nz.ORCID http://orcid.org/0000-0001-6468-7284
Ross WilsonHealth Economist & Research Fellow, Otago Medical School, Centre for Musculoskeletal Outcomes Research, University of Otago, Dunedin, New Zealand.
Yana PryymachenkoHealth Economist & Postdoctoral Fellow, Otago Medical School, Centre for Musculoskeletal Outcomes Research, University of Otago, Dunedin, New Zealand.
Saurab SharmaOtago Medical School, Postdoctoral Fellow, Centre for Musculoskeletal Outcomes Research, University of Otago, Dunedin, New Zealand.
Anupa PathakGraduate Research Student, Otago Medical School, Centre for Musculoskeletal Outcomes Research, University of Otago, Dunedin, New Zealand.
Jason Y Y ChuaGraduate Research Student, Otago Medical School, Centre for Musculoskeletal Outcomes Research, University of Otago, Dunedin, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding what an economic evaluation is, how to interpret it, and what it means for making choices in a health delivery context is necessary to contribute to decisions about healthcare resource allocation. The aim of this paper to demystify the working parts of a health economic evaluation, and explain to clinicians and clinical researchers how to read and interpret cost-effectiveness research. MAIN BODY: This primer distils key content and constructs of economic evaluation studies, and explains health economic evaluation in plain language. We use the PICOT (participant, intervention, comparison, outcome, timeframe) clinical trial framework familiar to clinicians, clinical decision-makers, and clinical researchers, who may be unfamiliar with economics, as an aide to reading and interpreting cost-effectiveness research. We provide examples, primarily of physiotherapy interventions for osteoarthritis.

conclusionsEconomic evaluation studies are essential to improve decisions about allocating resources, whether those resources be your time, the capacity of your service, or the available funding across the entire healthcare system. The PICOT framework can be used to understand and interpret cost-effectiveness research.

Indexed as

Cost effectivenessCost-effectiveness analysisCost-utility analysisEconomic evaluationHealth care economicsHealth economics

Identifiers

PMID36517825
PMCPMC9753355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.